Literature DB >> 17443703

Low plasma uric acid level in Parkinson's disease.

Tua Annanmaki1, Antti Muuronen, Kari Murros.   

Abstract

Earlier studies suggest that low plasma uric acid level is a risk factor for Parkinson's disease (PD), and that uric acid associates with iron-binding proteins. We therefore decided to examine plasma uric acid levels and markers of peripheral iron metabolism in PD patients and healthy controls. For the study, 40 patients with PD and 29 controls underwent clinical screening, laboratory testing, and body mass index (BMI) measurement. The average consumption of different foodstuffs and dairy products was estimated. Plasma uric acid level was significantly lower in the patients than in the controls. There were no significant differences in the levels of plasma iron parameters, but plasma uric acid correlated strongly with serum ferritin both in the patient and the control group. The BMI was slightly lower in the patients compared with the controls despite equal daily calorie consumption. Plasma uric acid level is low in patients with PD, which may have implications for both the disease pathogenesis and treatment recommendations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443703     DOI: 10.1002/mds.21502

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  41 in total

Review 1.  Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Authors:  Alvaro Alonso; Kelly A Sovell
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

2.  The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.

Authors:  Eugeniu Vieru; Ayhan Köksal; Belgin Mutluay; Ayten Ceyhan Dirican; Yavuz Altunkaynak; Sevim Baybas
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

3.  Orthostatic hypotension predicts motor decline in early Parkinson disease.

Authors:  Vikas Kotagal; Christina Lineback; Nicolaas I Bohnen; Roger L Albin
Journal:  Parkinsonism Relat Disord       Date:  2016-09-09       Impact factor: 4.891

4.  The risk of Parkinson disease associated with urate in a community-based cohort of older adults.

Authors:  S Jain; T G Ton; R M Boudreau; M Yang; E L Thacker; S Studenski; W T Longstreth; E S Strotmeyer; A B Newman
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

Review 5.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

6.  Impact of serum uric acid, albumin and their interaction on Parkinson's disease.

Authors:  Lijun Wang; Wei Hu; Jun Wang; Fangfang Fang; Guanliang Cheng; Yuzhang Jiang; Hang Xiao; Qi Wan
Journal:  Neurol Sci       Date:  2016-11-22       Impact factor: 3.307

7.  Relationship between uric acid levels and progressive supranuclear palsy.

Authors:  David M Brody; Irene Litvan; Steve Warner; David E Riley; Deborah A Hall; Benzi M Kluger; David R Shprecher; Christopher R Cunningham
Journal:  Mov Disord       Date:  2016-02-18       Impact factor: 10.338

8.  Gout and the risk of Parkinson's disease in Denmark.

Authors:  Eva Schernhammer; Jiaheng Qiu; Lene Wermuth; Christina Funch Lassen; Soren Friis; Beate Ritz
Journal:  Eur J Epidemiol       Date:  2013-03-02       Impact factor: 8.082

9.  Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study.

Authors:  Qi Hu; Anding Liu; Mengyang Huang; Luo Cheng; Huicong Kang; Feng Xu; Xiaoyan Liu; Lifei Lian; Qiming Liang; Hong Jiang; Cuntai Zhang; Suiqiang Zhu
Journal:  Neurol Sci       Date:  2014-01-25       Impact factor: 3.307

10.  Decreased NURR1 gene expression in patients with Parkinson's disease.

Authors:  Weidong Le; Tianhong Pan; Maosheng Huang; Pingyi Xu; Wenjie Xie; Wen Zhu; Xiong Zhang; Hao Deng; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2008-08-05       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.